what's compounded semaglutide Personalized Compound Semaglutide

Common side effects are nausea, vomiting, diarrhea, decreased appetite, headaches, and injection site reactions

Liraglutide and semaglutide are GLP-1 RAs whereas tirzepatide is a combined agonist to both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors

Tirzepatide SURMOUNT 1 trial: up to 22.5 percent weight loss at 72 weeks

Glucose-dependent insulinotropic peptide prevents serum deprivation-induced apoptosis in human bone marrow-derived mesenchymal stem cells and osteoblastic cells

Patients should understand that semaglutide is administered once weekly, not daily, as confusion between daily and weekly dosing represents one of the most common errors leading to inadvertent overdose

LDL cholesterol also dropped, improving overall lipid balance